GFM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.449400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.044200E-01
Normal-vs-Stage2
9.461800E-01
Normal-vs-Stage3
1.040030E-01
Normal-vs-Stage4
4.885800E-01
Stage1-vs-Stage2
1.129250E-01
Stage1-vs-Stage3
2.089800E-02
Stage1-vs-Stage4
5.659000E-01
Stage2-vs-Stage3
1.215950E-01
Stage2-vs-Stage4
4.787600E-01
Stage3-vs-Stage4
3.176200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.027400E-01
Normal-vs-AfricanAmerican
8.163000E-01
Normal-vs-Asian
8.144600E-01
Caucasian-vs-AfricanAmerican
7.122600E-01
Caucasian-vs-Asian
4.361800E-01
AfricanAmerican-vs-Asian
8.586000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.641400E-01
Normal-vs-Female
9.379000E-01
Male-vs-Female
3.300600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.418800E-01
Normal-vs-Age(41-60Yrs)
7.307800E-01
Normal-vs-Age(61-80Yrs)
9.496400E-01
Normal-vs-Age(81-100Yrs)
8.784800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.106000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.070200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.471800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.752840E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.553400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.775600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.417200E-01
Normal-vs-Daily Drinker
8.498200E-01
Normal-vs-Weekly Drinker
5.039400E-01
Normal-vs-Occasional Drinker
4.774600E-01
Normal-vs-Social Drinker
7.157600E-01
Non Drinker-vs-Daily Drinker
9.083000E-01
Non Drinker-vs-Weekly Drinker
5.648400E-01
Non Drinker-vs-Occasional Drinker
6.133800E-02
Non Drinker-vs-Social Drinker
2.699000E-01
Daily Drinker-vs-Weekly Drinker
4.345800E-01
Daily Drinker-vs-Occasional Drinker
6.484000E-02
Daily Drinker-vs-Social Drinker
2.847800E-01
Weekly Drinker-vs-Occasional Drinker
3.143600E-02
Weekly Drinker-vs-Social Drinker
1.388640E-01
Occasional Drinker-vs-Social Drinker
5.710200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.245600E-01
Normal-vs-Grade 2
7.698100E-02
Normal-vs-Grade 3
6.591700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.398000E-01
Grade 1-vs-Grade 3
3.546600E-01
Grade 1-vs-Grade 4
2.245600E-01
Grade 2-vs-Grade 3
6.508800E-01
Grade 2-vs-Grade 4
7.698100E-02
Grade 3-vs-Grade 4
6.591700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.598200E-01
Normal-vs-NonDiabetic
9.511600E-01
Diabetic-vs-NonDiabetic
7.237200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.413200E-01
Normal-vs-NoPancreatitis
9.730400E-01
Pancreatitis-vs-NoPancreatitis
5.071600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.683600E-01
Normal-vs-N1
8.951600E-01
N0-vs-N1
1.541180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.693000E-01
Normal-vs-TP53-NonMutant
5.771400E-01
TP53-Mutant-vs-TP53-NonMutant
2.463400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
